BERTIS is a proteomics technology company that employs bioinformatics and proteomics to identify essential biomarkers for identifying cancer and other disorders.
Bertis distinguishes out in the field of quantitative proteomics because of its extensive technical platform. They cover the full process, from finding protein biomarkers to creating diagnostic solutions. This enables them to do extensive research and development on diagnostic solutions for a variety of malignancies and serious disorders.
PASS Panomics Analysis Service & Solution
PASS is an analysis solution optimized for academia and pharma research. The proprietary solution was derived from proven technology and innovation embedded in Mastocheck, a proteomics-based early cancer diagnostics approved by Ministry of Food and Drug Safety (MFDS).
Bertis PASS
PASS is a platform for integrative analysis of pan-omics data based on its proven and reliable bioinformatics analysis capabilities. Their team consists of experienced scientists with an extensive track record of research achievements spanning more than a decade in mass spectrometry-based proteomics.
Bertis possesses the core expertise and proprietary technology for pan-omics (multi-omics) analysis to provide customized solutions in all fields where omics data analysis is applicable.
With PASS, you can leverage Bertis’ scientific resources and cutting-edge tools to advance your research projects and goals, from the design stage to the interpretation and visualization of bioinformatics analysis results.
GP-PASS Global proteomics (Cell, Tissue, blood proteome)
Label-free quantification of peptide/protein
Label-free analysis based on data-independent acquisition (DIA)
Their industry-leading protein analysis of non-depleted plasma can result in 1,300 protein identifications in one hour per single sample.
Their isotope labeling enables a sample-to-sample comparison analysis in protein quantification.
Bertis labeling quantification and advanced fractionation technology enable industry-leading protein quantification analysis in cell or tissue samples.
Their phospho/glycoprotein proteomics ensure high-quality post-translational modification (PTM) analysis of proteins, providing an optimized solution for biomarker discovery and mechanism of action analysis.
Click here to contact Bertis
View more: Panomics Analysis Service and Solution
